TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ORGO

Organogenesis Holdings Inc

Healthcare · Drug Manufacturers - Specialty & Generic

1.40$ +4.4% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Organogenesis Holdings Inc (ORGO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 599 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ORGO
Line item 2001 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
2.6 0.4 311 313 164 221 290 443 449 460 498 599
0.7 0.1 1.4 0.3 71 126 174 227 223 225 286 362
0.2 0.1 1.0 0.1 21 60 84 114 102 104 136 94
0.1 1.0 0.1 21 60 84 114 102 104 136 94
0.2 19 28 34 39 57 82 89 82 110 217
0.2 14 14 13 23 28 25 25 28 26 30
1.8 45 42 40 47 60 79 102
0.0 6.1 26 26 26 29 29 29 29 29 29
0.0 11 30 26 21 31 26 21 16 12 9.1
4.7 0.4 11 15 117 165 148 202 184 181 113 165
1.0 0.4 0.5 3.9 66 60 68 83 75 81 77 100
0.0 0.2 0.0 5.5 4.8 3.1 20 15 16 20 9.1 19
0.5 12 19 19 28 23 29 32 31 29 32
2.5 73 89 39 83 53 71 66 61
-2.1 0.0 300 298 47 56 142 241 266 279 385 434
-18 0.0 -0.2 -2.3 -130 -171 -155 -61 -45 -41 -40 -3.1
63 8.6 64 69 93 111 134 132 133 132 130

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?